{"schema_version":"secwatch.filing_event.v1","accession":"0000716643-22-000023","form_type":"8-K","ticker":"RGS","cik":"0000716643","company_name":"REGIS CORP","filed_at":"2022-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.452501+00:00","generated_at":"2026-06-26T00:06:33.710047+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Regis appoints Matthew Doctor as permanent President and CEO, effective May 5, 2022","bullets":["Matthew Doctor, 35, appointed President & CEO and director; had been interim CEO since Dec 2021.","Base salary $600K/yr, target bonus 125% of base, max payout 225%; granted options for 875,000 shares.","Options vest 20% on 1st anniversary, 20% on 2nd, 60% on 3rd; exercise price = closing price on grant date.","Doctor previously EVP & Chief Strategy Officer at Regis, earlier at Restaurant Brands International and J.P. Morgan.","Board chair David Grissen: 'Matt has stabilized the team, built trust with franchisees, laid groundwork for future.'"],"urls":{"canonical":"https://secwatch.observer/filing/0000716643-22-000023","json":"https://secwatch.observer/filing/0000716643-22-000023.json","markdown":"https://secwatch.observer/filing/0000716643-22-000023.md","text":"https://secwatch.observer/filing/0000716643-22-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/716643/000071664322000023/0000716643-22-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/716643/000071664322000023/rgs-20220504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T00:06:33.710047+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7c2f99fc46","claim":"Matthew Doctor was appointed as Director at REGIS CORP.","evidence_excerpt":"On May 5, 2022, Regis Corporation (the \"Company\") announced Matthew Doctor as the Company's President and Chief Executive Officer (CEO) and will be appointed as a director on the Company's Board of Directors (the \"Board\") effective May 5, 2022 (\"Start Date\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/716643/000071664322000023/0000716643-22-000023-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"9de0b5a70e","claim":"Matthew Doctor was appointed as President and Chief Executive Officer at REGIS CORP.","evidence_excerpt":"On May 5, 2022, Regis Corporation (the \"Company\") announced Matthew Doctor as the Company's President and Chief Executive Officer (CEO) and will be appointed as a director on the Company's Board of Directors (the \"Board\") effective May 5, 2022 (\"Start Date\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/716643/000071664322000023/0000716643-22-000023-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}